Revenue growth has plummeted to -100% in 2026Q1, while SG&A expenses of $1.9 million continue to outpace the company's negative gross profit.
| Sales/Revenue | -66K | 0 | 210K | 263.44K | 394K | 438.14K | 232.27K | 175.82K | 426.59K | 343.93K | 321.97K |
| Revenue Growth % | -128.37% | -100% | -20.29% | -33.14% | -10.07% | 88.63% | 32.11% | -58.78% | 24.04% | 6.82% | - |
| Cost of Goods Sold | 110K | 79K | 165K | 55.18K | 158.31K | 135.94K | 43.41K | 144.55K | 136.84K | 141.77K | 245.94K |
| COGS % of Revenue | - | - | 78.57% | 20.94% | 40.18% | 31.03% | 18.69% | 82.21% | 32.08% | 41.22% | 76.39% |
| Gross Profit | -176K | -79K | 45K | 208.27K | 235.69K | 302.2K | 188.87K | 31.27K | 289.75K | 202.15K | 76.03K |
| Gross Margin % | 266.67% | - | 21.43% | 79.06% | 59.82% | 68.97% | 81.31% | 17.79% | 67.92% | 58.78% | 23.61% |
| Gross Profit Growth % | - | -275.56% | -78.39% | -11.64% | -22.01% | 60% | 503.9% | -89.21% | 43.33% | 165.89% | - |
| Operating Expenses | 6.66M | 4.95M | 4.37M | 7.79M | 6.06M | 5.01M | 1.54M | 1.96M | 771.7K | 896.31K | 1.01M |
| OpEx % of Revenue | - | - | 2078.57% | 2955.47% | 1536.87% | 1142.52% | 662.24% | 1116.22% | 180.9% | 260.61% | 314.82% |
| Selling, General & Admin | 6.29M | 5.11M | 3.99M | 5.8M | 5.28M | 4.21M | 1.08M | 1.34M | 457.9K | 573.58K | 689.69K |
| SG&A % of Revenue | - | - | 1901.9% | 2201.26% | 1339.17% | 961.73% | 464.46% | 759.98% | 107.34% | 166.77% | 214.21% |
| Research & Development | 434K | 179K | 369K | 1.94M | 770.83K | 538.68K | 417K | 615.62K | 296.28K | 308.85K | 323.91K |
| R&D % of Revenue | - | - | 175.71% | 735.73% | 195.64% | 122.95% | 179.53% | 350.14% | 69.45% | 89.8% | 100.6% |
| Other Operating Expenses | -59K | -338K | 2K | 48.69K | 8.11K | 253.44K | 42.39K | 10.73K | 17.52K | 13.88K | 0 |
| Operating Income | -6.84M | -5.03M | -4.32M | -7.58M | -5.82M | -4.7M | -1.35M | -1.93M | -481.96K | -694.16K | -937.57K |
| Operating Margin % | 10362.12% | - | -2057.14% | -2876.42% | -1477.05% | -1073.54% | -580.93% | -1098.44% | -112.98% | -201.83% | -291.2% |
| Operating Income Growth % | - | -16.41% | 42.99% | -30.21% | -23.73% | -248.59% | 30.13% | -300.72% | 30.57% | 25.96% | - |
| EBITDA | -6.67M | -4.95M | -4.3M | -7.56M | -5.76M | -4.65M | -1.3M | -1.9M | -443.07K | -677.42K | -917.76K |
| EBITDA Margin % | 10103.03% | - | -2048.57% | -2868.51% | -1463.16% | -1060.49% | -561.47% | -1082.88% | -103.86% | -196.97% | -285.05% |
| EBITDA Growth % | -66.5% | -15.06% | 43.07% | -31.08% | -24.07% | -256.28% | 31.5% | -329.72% | 34.59% | 26.19% | - |
| D&A (Non-Cash Add-back) | 171K | 79K | 18K | 20.84K | 54.72K | 57.2K | 45.2K | 27.35K | 38.89K | 16.74K | 19.81K |
| EBIT | -9.05M | -3.5M | -5.25M | -7.54M | -5.77M | -4.86M | -1.4M | -1.99M | -518.66K | -936.45K | -937.57K |
| Net Interest Income | -1.12M | -114K | -30K | 60.4K | 24.94K | -152.07K | -236.36K | -43.41K | 49.8K | 0 | 0 |
| Interest Income | 183K | 0 | 65K | 65.76K | 33.74K | -143.73K | -33.44K | - | 20.49K | 0 | 0 |
| Interest Expense | 1.3M | 114K | 95K | 5.36K | 8.8K | 8.34K | 202.92K | 43.41K | -29.31K | 21.25K | 18.2K |
| Other Income/Expense | -2.96M | 1.42M | -1.03M | 317.86K | 39.8K | -161.74K | -257.24K | -59.1K | 36.98K | -263.55K | -18.2K |
| Pretax Income | -9.8M | -3.61M | -5.35M | -7.26M | -5.78M | -4.87M | -1.61M | -1.99M | -444.99K | -957.7K | -955.77K |
| Pretax Margin % | 14853.03% | - | -2546.19% | -2755.76% | -1466.95% | -1110.46% | -691.67% | -1132.05% | -104.31% | -278.46% | -296.85% |
| Income Tax | -41K | -18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.42% | 0.5% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.27M | -4M | -5.19M | -6.52M | -5.74M | -4.82M | -1.59M | -1.97M | -356.89K | -672.14K | -599.49K |
| Net Margin % | 15562.12% | - | -2472.86% | -2475.81% | -1456.74% | -1100.23% | -685.89% | -1121.25% | -83.66% | -195.43% | -186.2% |
| Net Income Growth % | -82.89% | 22.9% | 20.38% | -13.64% | -19.06% | -202.58% | 19.19% | -452.38% | 46.9% | -12.12% | - |
| Net Income (Continuing) | -9.76M | -3.6M | -5.35M | -7.26M | -5.78M | -4.87M | -1.61M | -1.99M | -444.99K | -957.7K | -955.77K |
| Discontinued Operations | -606K | -561K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -111K | -280K | -176K | -21.43K | -109.04K | -70.67K | -29.28K | -21.05K | -6.71K | -293.57K | -275.02K |
| EPS (Diluted) | -0.02 | -3.57 | -31.15 | -190.05 | -379.75 | -504.00 | -256.90 | -339.15 | -91.70 | -743.05 | -1699.25 |
| EPS Growth % | 21.67% | 88.54% | 83.61% | 49.95% | 24.65% | -96.19% | 24.25% | -269.85% | 87.66% | 56.27% | - |
| EPS (Basic) | - | -3.54 | -31.15 | -190.05 | -379.75 | -504.00 | -256.90 | -339.15 | -91.70 | -743.05 | -1699.25 |
| Diluted Shares Outstanding | 612.72M | 1.29B | 166.29M | 34.3M | 15.11M | 9.56M | 6.2M | 5.81M | 3.89M | 905K | 353K |
| Basic Shares Outstanding | 612.72M | 1.13B | 166.29M | 34.3M | 15.11M | 9.56M | 6.2M | 5.81M | 3.89M | 905K | 353K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |
Total commercial revenue collapse
As indicated by the most recent quarterly filings, NITO's revenue growth has plummeted to -100% year-over-year, effectively signaling a total cessation of commercial activity that leaves the company without a functional sales engine to support its ongoing operational expenses or long-term strategic objectives.
The complete disappearance of top-line revenue suggests that previous pilot programs or product distributions have failed to convert into a sustainable, recurring business model. Investors should interpret this as a fundamental reset, as the company appears to be struggling to find product-market fit within the competitive agri-tech landscape.
Based on the reported financial statements, the company's SG&A expenses of $1.9 million in 2026Q1 significantly outweigh its gross profit, which remains negative, highlighting a structural inability to cover basic operating costs without a consistent stream of revenue to offset these persistent overhead burdens.
The cost structure appears heavily skewed toward administrative and overhead expenses rather than revenue-generating activities. This imbalance suggests that management is currently prioritizing corporate maintenance over commercial scaling, which may lead to further erosion of the company's limited cash reserves.
According to historical income statement data, the company's net income has exhibited extreme volatility, including a $1.3 million gain in 2025Q4 followed by a $7.5 million loss in 2026Q1, suggesting that non-operating items or accounting adjustments are significantly distorting the true economic reality of the business.
The erratic nature of the bottom line, coupled with inconsistent stock-based compensation charges, makes it difficult to ascertain the company's core operational performance. Analysts should view these figures with caution, as they likely reflect accounting noise rather than genuine improvements in the underlying business model.
While proponents might argue that NITO's residue-free chemistry positions it to benefit from tightening EU regulations, the lack of any meaningful revenue generation suggests that this potential regulatory tailwind has yet to translate into tangible commercial demand or a defensible competitive advantage in the marketplace.
The thesis that NITO can capture market share through regulatory arbitrage appears speculative at best given the current absence of sales. Without evidence of successful adoption by packing houses, the company remains a high-risk entity that may be unable to capitalize on the very regulatory shifts it targets.
Quick answers to the most common questions about buying NITO stock.
For fiscal year 2025, Nexentis Technologies Inc. (NITO) reported total revenue of $0.0M. This represents a 100.0% decline compared to $0.3M in 2016.
Nexentis Technologies Inc. (NITO) reported a net loss of $4.0M for the fiscal year ending 2025.